INTRODUCTION
============

Physical exercise is widely recognized for its beneficial effects on cardiovascular, respiratory, and muscular systems \[[@b1-ir-2018-00162],[@b2-ir-2018-00162]\]. However, physical exercise also triggered effects on physiological systems which were not directly related to the exercise such as the GI system \[[@b3-ir-2018-00162]\]. Indeed, the impact of physical exercise on the GI system, both in experimental models and in humans, is an area of great interest \[[@b4-ir-2018-00162]-[@b7-ir-2018-00162]\]. For example, moderate physical exercise may act as a modulator of GI function, because it may prevent diseases such as colon cancer, cholelithiasis, diverticulitis, IBD, and constipation \[[@b5-ir-2018-00162],[@b8-ir-2018-00162]\]. On the other hand, high intensity and long duration physical exercise triggers GI symptoms \[[@b3-ir-2018-00162],[@b5-ir-2018-00162],[@b8-ir-2018-00162],[@b9-ir-2018-00162]\], which may occur at rest or during physical exercise session \[[@b5-ir-2018-00162],[@b8-ir-2018-00162],[@b10-ir-2018-00162]-[@b16-ir-2018-00162]\]. When these symptoms occur during physical exercise, they may impair an individual's ability to perform physical effort and result in interruption in severe cases \[[@b10-ir-2018-00162],[@b12-ir-2018-00162],[@b17-ir-2018-00162]\]. GI symptoms can be divided into upper (upper abdominal bloating, epigastric pain, vomiting, nausea, belching, heartburn, and loss of appetite) and lower (flatulence, diarrhea, abdominal cramps, bleeding, accelerated bowel movements, and urge to defecate) \[[@b3-ir-2018-00162]\].

The prevalence of GI symptoms in elite endurance athletes, such as marathon runners, triathletes, and cyclists, has been well described in the literature and can attain rates of up to 90% depending on the methodology used and events studied \[[@b10-ir-2018-00162]\]. More specifically, the prevalence of diarrhea and accelerated bowel movements among marathoners is 38% and 53%, respectively \[[@b17-ir-2018-00162]\]. The triggering of GI symptoms may be attributed to physiological, mechanical, or nutritional factors \[[@b3-ir-2018-00162],[@b18-ir-2018-00162],[@b19-ir-2018-00162]\]. During intense exercise, and especially in a hypohydrated state, mesenteric blood flow is decreased \[[@b10-ir-2018-00162]\]. This is believed to be one of the main contributors to the development of GI symptoms, since reduced splanchnic perfusion may result in compromised gut permeability in athletes \[[@b10-ir-2018-00162]\]. By different mechanisms, athletes that perform anaerobic sports such as weightlifting, which cause high levels of intra-abdominal pressure, also present GI symptoms, including heartburn and gastroesophageal reflux \[[@b20-ir-2018-00162]\]. It is noteworthy that GI symptoms may also affect the individual at rest state \[[@b16-ir-2018-00162]\].

Despite this knowledge available in the literature and evidence of a modest prevalence of GI symptoms in recreational runners \[[@b21-ir-2018-00162]\], the frequency and intensity of GI symptoms in exercisers individuals (nonathletes) have been less investigated. Therefore, further studies to elucidate the prevalence of GI symptoms in exercisers people at rest and during physical exercise training session are needed. Thus, the aims of the present study were to investigate the frequency and intensity of GI symptoms, during rest and physical exercise training session, in individuals that practice different types of moderate or vigorous physical exercise for recreational and health purposes. It was hypothesized that exercisers, but nonathletes, present GI symptoms at rest and during exercise, akin to endurance athletes, however these symptoms are of moderate intensity given the lower intensity and duration of exercise performed by this population. In addition, it was hypothesized that intensity and frequency of these symptoms are greater during resting state as compared to physical exercise since is known that physical exercise acts as regulator of GI function. Finally, it was hypothesized that intensity and frequency of these symptoms are greater in individuals that performing vigorous physical exercise as compared with individuals that performing moderate physical exercise. A better understanding of the frequency and intensity of GI symptoms in this population may help guide exercise prescription and be useful in treatment and prevention programs for GI diseases and symptoms.

METHODS
=======

1. Participants
---------------

This was a cross-sectional study of 142 trained individuals (78 men and 64 women). Participants from different states of Brazil were recruited over the internet. All participants were engaged in regular physical exercise programs of, at least, moderate intensity for at least 2 months. To the end of current study, we considered regular physical exercise that physical exercise performed for at least 2 months, since previous studies investigating training effects had found positive physiological adaptations with 2 months of training \[[@b22-ir-2018-00162]-[@b24-ir-2018-00162]\]. Respondents under the age of 18, athletes, who performed physical exercise of very, very light; very light, and light intensity and who had GI diseases or other disease that influence GI function, who used medical drugs that influence GI function and/or were submitted to gastric or intestinal surgery were excluded. For the purposes of current study, we consider as athlete who participates in an organized team or individual sport that requires regular competition against others as a central component, places a high premium on excellence and achievement, and requires systematic training \[[@b25-ir-2018-00162]\]. The participants were divided in 2 groups: physical exercise of moderate intensity group (comprised by participants that reported to perform physical exercise of moderate intensity: n = 71, 37 women) and physical exercise of vigorous intensity group (comprised by participants that reported to perform physical exercise of vigorous intensity: n = 71, 27 women). The characteristics of the participants are shown in [Table 1](#t1-ir-2018-00162){ref-type="table"}. The Mann-Whitney *U*-test revealed significant differences between group for height, experience in physical exercise, weekly frequency of physical exercise, hours per day of physical exercise and intensity of physical exercise.

Participants were informed about the aims and procedures of the study by a text over the internet (available at <https://docs.google.com/spreadsheet/viewform?formkey=dExTTkpyaWJLWXlXdUZSMGlQcW5QMnc6MQ#gid=0>). Voluntary and full completion of the questionnaire was taken to indicate that the participants agreed with the objectives of the study and felt clearly informed about the experimental procedures. All experimental procedures were approved by the Federal University of Goiás Human Research Ethics Committee (approval number: 066/2013) and conformed to the principles outlined in the Helsinki Declaration.

2. Questionnaire
----------------

A questionnaire was devised (available at <https://docs.google.com/spreadsheet/viewform?formkey=dExTTkpyaWJLWXlXdUZSMGlQcW5QMnc6MQ#gid=0>), based on a thorough review of the specialized literature, to investigate the frequency and intensity of GI symptoms at rest and during physical exercise training session. The questionnaire comprised 3 parts: first, personal data and training information (age, body mass, height, gender, exercise modalities, intensity of training sessions, weekly training frequency \[number of sessions per week\], and length of each training session \[in hours\]); second, weekly frequency and intensity of GI symptoms in the resting state; and third, weekly frequency and intensity of GI symptoms during physical exercise. To answer on the frequency and intensity of GI symptoms during rest, the volunteers were instructed not to take into account the period of up to 3 hours after the end of the exercise. The following GI symptoms (in rest state and during physical exercise training session) were assessed: epigastric pain, regurgitation, nausea, vomiting, early satiety, dysphagia, bloating, eructation, abdominal noise, abdominal cramps (lower abdominal pain), blood in stools, diarrhea, constipation, steatorrhea, mucus stools, loss of appetite, and heartburn. In order to aid understanding, each symptom contained in the list was accompanied by the corresponding terms used by the lay population.

Likert type scales \[[@b26-ir-2018-00162]\] in the 1--7 or 1--5 range were adopted to evaluate "intensity of the physical exercise training sessions" (1, very, very light; 2, very light; 3, light; 4, moderate; 5, intense; 6, very intense; and 7, maximal), "weekly frequency index of GI symptoms" (1, indicated no GI symptoms; 2, rarely; 3, sometimes; 4, frequently; and 5, always), and "intensity index of GI symptoms" (1, indicated no GI symptoms; 2, very light; 3, light; 4, moderate; 5, intense; 6, very intense; and 7, maximal). Likert scale to assess intensity of the physical exercise training session was created and adapted from American College of Sports Medicine guidelines \[[@b1-ir-2018-00162]\]. Again, participants that reported to perform very, very light; very light, and light physical exercise were excluded from sample. Participants that reported to perform intense, very intense, and maximal physical exercise were grouped in physical exercise of vigorous intensity group.

3. Statistical Analysis
-----------------------

Data were analyzed using the software application SPSS version 21.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were used to analyze the data (mean and SD, and absolute and relative frequencies). The absolute frequency of each GI symptom was calculated by adding up the number of individuals that reported the symptoms, i.e., those who marked 2, 3, 4, or 5. Relative frequency of each GI symptom was calculated by dividing the absolute frequency by total number of individuals in the sample, expressed as a percentage. The McNemar test was used to evaluate the GI symptoms during rest and during physical exercise training session.

The Mann-Whitney *U*-test was used to compare variables between the groups (moderate and vigorous group). Additionally, frequency was evaluated by a "weekly frequency index of GI symptoms" which consisted of assessing the mean and standard deviation of the responses given in the questionnaire. The same procedure was adopted for intensity "intensity index of GI symptoms." These data were compared between groups using two-way ANOVA (group \[moderate × vigorous\] × state \[rest × physical exercise\]). The level of significance was *P*\< 0.050.

RESULTS
=======

Of the 142 individuals investigated, 68 practiced resistance training, 64 running/walking, 18 swimming, 11 soccer, 14 cycling, 12 martial arts/fighting, 2 functional training, 5 volleyball, 6 triathlon, 5 Pilates, 4 tennis, 2 surfing, 2 yoga, 2 stretching, 2 dance, and 1 basketball. In addition, 82 practiced only 1 modality, 34 practiced 2 modalities, 18 practiced 3 modalities, 6 practiced 4 modalities, and 2 practiced 5 modalities. The average intensity of exercise reported during training session, considering all modalities, was 4.7 ± 0.8, which corresponded to an estimated moderate exercise intensity according to scale proposed by current study. Specifically, 71 (50%) report that performed physical exercise of "moderate" intensity and 71 (50%) report that performed "vigorous" physical exercise ([Table 1](#t1-ir-2018-00162){ref-type="table"}).

Overall, the most prevalent symptoms were flatulence, abdominal noise, and eructation ([Table 2](#t2-ir-2018-00162){ref-type="table"}). In addition, except for regurgitation, nausea, dysphagia, blood in stools, steatorrhea and loss of appetite, the McNemar test revealed a high proportion of GI symptoms in resting state compared with physical exercise training session.

To assess the frequency and intensity indexes of GI symptoms, we divided the sample into 2 groups (moderate physical exercise and vigorous physical exercise groups) according described in methods section. For frequency index of GI symptoms, the two-way ANOVA did not reveal state (rest × physical exercise) and group (moderate × vigorous) interaction for any GI symptoms (*P*\> 0.050). However, two-way ANOVA revealed effect of state (*P*\> 0.050, lower weekly frequency index of GI symptoms during exercise for both groups) for following symptoms: epigastric pain, vomiting, early satiety, bloating, eructation, abdominal noise, abdominal cramps, flatulence, diarrhea, constipation and mucus in stools. Descriptive data about frequency index of GI symptoms of the participants are presented in [Table 3](#t3-ir-2018-00162){ref-type="table"}. When data were analyzed together, weekly frequency index of GI symptoms were 1.61 ± 0.38 and 1.35 ± 0.36 at rest and at physical exercise training session, respectively, for moderate group and 1.70 ± 0.30 and 1.44 ± 0.33 at rest and at physical exercise training session, respectively, for vigorous group.

Regards to intensity index of GI symptoms, the two-way ANOVA did not reveal state (rest × physical exercise) and group (moderate × vigorous) interaction for any GI symptoms (*P*\> 0.050). However, two-way ANOVA revealed effect of state (*P*\> 0.050, lower intensity index of GI symptoms during exercise for both groups) for following symptoms: epigastric pain, early satiety, bloating, eructation, abdominal noise, abdominal cramps, flatulence, diarrhea, constipation and mucus in stools. Descriptive data about intensity index of GI symptoms of the participants are presented in [Table 4](#t4-ir-2018-00162){ref-type="table"}. When data were analyzed together, intensity index of GI symptoms were 1.78 ± 0.41 and 1.46 ± 0.40 at rest and at physical exercise training session, respectively, for moderate group and 1.86 ± 0.39 and 1.54 ± 0.37 at rest and at physical exercise training session, respectively, for vigorous group.

DISCUSSION
==========

Studies have shown that endurance physical exercise, such as that performed by marathoners, triathletes and cyclists can cause GI symptoms which may impair physical performance \[[@b10-ir-2018-00162]\]. However, there is little information on the frequency and intensity of GI symptoms in exercisers nonathletes individuals. Thus, the aim of this study was to evaluate the frequency and intensity of GI symptoms in a sample of exercisers nonathletes individuals at resting state and during physical exercise training session. The main result was that individuals present GI symptoms at rest and during physical exercise training session, akin to endurance athletes, however these symptoms are of very light intensity. In addition, the frequency and intensity of GI symptoms was found to be lower during physical exercise training session than in the rest state, suggesting that physical exercise may act as a modulator of GI function. Furthermore, there were no difference in frequency and intensity of GI symptoms between moderate and vigorous physical exercise groups.

The predisposition to present some type of GI symptoms depends on factors such as the type of sport practiced, duration and intensity of the physical exercise, age, training status, gender, and type of diet \[[@b8-ir-2018-00162]\]. With regards to lower GI symptoms, diarrhea affects 8% to 54% whereas abdominal cramps (lower abdominal pain), blood in stools and flatulence affect 33%, 2% to 16%, and 38% of athletes, respectively \[[@b27-ir-2018-00162],[@b28-ir-2018-00162]\]. In the present study, the respondents reported diarrhea (36.6% and 26.1%), abdominal cramps (lower abdominal pain) (40.8% and 21.8%), presence of blood in stools (6.3% and 3.5%), and bloating (64.1% and 29.6%), at rest and during physical exercise training session, respectively. Except for flatulence, the prevalences of GI symptoms found in the present study were similar to those described in the literature for endurance athletes.

Considering upper GI symptoms in athletes, loss of appetite is experienced by 12% to 50%, eructation 12% to 36%, nausea 4% to 21%, vomiting 2% to 31%, and heartburn by 8% to 10% \[[@b17-ir-2018-00162],[@b29-ir-2018-00162],[@b30-ir-2018-00162]\]. In the present study, 18.3% and 14.1% reported loss of appetite; 73.9% and 52.1% eructation; 31.0% and 25.4% nausea; 7.0% and 0.7% vomiting; and 50.7% and 42.3% heartburn, at rest and during physical exercise, respectively. Except for loss of appetite and vomiting, the prevalence of GI symptoms found in the present study were similar to those described by the literature for endurance athletes. On the comparison of the prevalence of lower and upper GI symptoms, except for vomiting, upper GI symptoms were more prevalent. These results are in line with those of Sullivan \[[@b29-ir-2018-00162]\], who also found that upper GI symptoms were more prevalent during the rest state and in sedentary individuals \[[@b29-ir-2018-00162]\] and that lower GI symptoms were more prevalent in endurance athletes \[[@b14-ir-2018-00162],[@b29-ir-2018-00162]\]. Therefore, it is reasonable to suppose that the higher prevalence of upper than lower GI symptoms found in the present study might be due to the fact that participants were not elite athletes, thus more closely resembling sedentary individuals than elite athletes from a functional perspective.

Although the prevalence of GI symptoms in our sample proved similar to rates in athletes performing high intensity endurance activities, the symptoms reported by individuals in this study were of very light intensity both at rest and during physical exercise training session. These findings are in accordance with our hypothesis. Furthermore, comparison of weekly frequency and intensity index of GI symptoms at rest versus during physical exercise training session revealed symptoms with higher frequency and intensity during rest, suggesting that physical exercise may act as a regulator of the GI system. Indeed, a plethora of studies showed that physical exercise may influence the GI tract function by decrease GI blood flow, increase in GI motility, increase mechanical bouncing and neuro-immuno-endocrine alterations \[[@b31-ir-2018-00162]-[@b33-ir-2018-00162]\]. Many hormones associated with GI function at rest (secretion, absorption, and motility) alter during exercise, in terms of plasma concentrations: cholecystokinin, vasoactive intestinal peptide, secretin, pancreatic polypeptide, somatostatin, peptide histidine isoleucine, peptide YY, gastrin, glucagon, motilin, catecholamines, endorphins, and prostaglandins \[[@b33-ir-2018-00162]-[@b35-ir-2018-00162]\].

Pugh et al. \[[@b36-ir-2018-00162]\] reported for the first time that acute high intensity interval running (18 × 400 m interval efforts at 120% of maximum oxygen uptake interspaced by running at a velocity associated with 50% of maximum oxygen uptake for an amount of time equal to 75% of that taken to run the 400 m) increases intestinal cellular damage and GI permeability in 11 trained male runners though such markers do not correlate to symptoms of GI discomfort; however, the low scores for GI discomfort found by the authors may be explained due to the fact that the individuals were healthy trained males and had no history of GI disease. Moreover, they were also well hydrated and habituated to the high intensity interval running.

A few limitations of the present study must be mentioned. First, as for all studies employing questionnaires, the present results rely on the honesty and level of recall of respondents. Second, the present study was that type of diet was not evaluated, a factor that can impact GI function. Third, we assessed volunteers that practiced a great variety of exercise (e.g., running and resistance training). Fourth, the intensity of physical exercise used in the analysis was reported by volunteers it was not possible to determine the true training status of the individuals. Fifth, we did not ask about GI disease, such as lactose intolerance, celiac disease, or IBS. Sixth, we did not assess symptoms that occurred in the first few hours after exercise. Seventh, volunteers were recruited over the internet thus forming a convenience sample. In this context, interest in participating in the study may have been higher among those who had already developed GI symptoms. To minimize this problem, the study was made known on social media and the University website. Therefore, we believe that the large number of respondents diluted this potential bias. Nevertheless, we believe that these limitations do not prevent conclusions being drawn from the study because we use a "ecological validity" approach.

The use of internet-based questionnaire has several methodological advantages: the interface is user-friendly, the questionnaire can be answered in 5 to 10 minutes and by people from different regions, the analysis is quick and easy because all the results can be placed directly into a database, the questionnaire guides the respondent, and therefore prevents incorrect and/or inconsistent answers, and there is no need to interpret erasures.

Most previous studies evaluated 3 to 5 GI symptoms whereas this study 18 GI symptoms were evaluated. We also evaluated the frequency and intensity of GI symptoms of physically active individuals while performing the physical exercise compared to the rest state while most other studies have evaluated GI symptoms only during the practice of physical exercise. Additionally, we evaluated subjects who performed different modalities of physical exercise while previous studies investigated athletes that performed only endurance physical exercise. Thus, we believe that the results of this study represent a breakthrough for exercise physiology applied to the GI tract, showing that not only endurance athletes suffer from GI symptoms.

Finally, this study proposes a method for assessing frequency and intensity of GI symptoms. In the literature, to the best of our knowledge, there is no current definition of what constitutes a severe or non-severe symptom in exercisers individuals. Therefore, the questionnaire used in this study may represent a useful approach for categorizing symptoms. In summary, our data indicated that physical exercise performed by exercisers individual can trigger GI symptoms. However, the symptoms in the present sample were of very light intensity. Furthermore, several GI symptoms in exercisers individuals were more prevalent during rest than physical exercise for both moderate and vigorous groups, suggesting that physical exercise may act as a regulator of the GI tract.
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###### 

Characteristics of Participants (n=142)

  Variable                                Group           *P*-value       
  --------------------------------------- --------------- --------------- ----------
  Age (yr)                                34.04 ± 11.25   31.66 ± 10.07   0.442
  Height (m)                              1.69 ± 0.09     1.72 ± 0.07     0.021
  Body mass (kg)                          70.39 ± 15.23   72.78 ± 13.21   0.185
  BMI (kg/m^2^)                           24.50 ± 3.78    24.43 ± 3.60    0.977
  Experience in physical exercise (yr)    7.22 ± 8.47     11.50 ± 10.79   0.013
  Weekly frequency of physical exercise   3.46 ± 1.30     4.52 ± 1.37     \< 0.001
  Physical exercise (hr/day)              1.25 ± 0.50     1.67 ± 0.87     \< 0.001
  Intensity of physical exercise          4.00 ± 0.00     5.30 ± 0.52     \< 0.001

Values are presented as mean±SD.

###### 

Absolute (and Relative) Frequency of GI Symptoms during Rest and Physical Exercise (n=142)

  Symptom            Rest         Physical exercise   *P*-value
  ------------------ ------------ ------------------- -----------
  Epigastric pain    46 (32.4)    28 (19.7)           0.001
  Regurgitation      47 (33.1)    40 (28.2)           0.210
  Nausea             44 (31.0)    36 (25.4)           0.115
  Vomiting           10 (7.0)     1 (0.7)             0.004
  Early satiety      77 (54.2)    46 (32.4)           \< 0.001
  Dysphagia          11 (7.7)     10 (7.0)            1.000
  Bloating           91 (64.1)    42 (29.6)           \< 0.001
  Eructation         105 (73.9)   74 (52.1)           \< 0.001
  Abdominal noise    110 (77.5)   59 (41.5)           \< 0.001
  Abdominal cramps   58 (40.8)    31 (21.8)           \< 0.001
  Flatulence         129 (90.8)   99 (69.7)           \< 0.001
  Blood in stools    9 (6.3)      5 (3.5)             0.125
  Diarrhea           52 (36.6)    37 (26.1)           0.003
  Constipation       60 (42.3)    41 (28.9)           \< 0.001
  Steatorrhea        7 (4.9)      3 (2.1)             0.125
  Mucus in stools    21 (14.8)    12 (8.5)            0.004
  Loss of appetite   26 (18.3)    20 (14.1)           0.286
  Heartburn          72 (50.7)    60 (42.3)           0.023

Values are presented as number (%).

###### 

Comparison of Weekly Frequency Index of GI Symptoms during Rest and Physical Exercise

  Symptom            Group         *P*-value (intensity) (moderate×vigorous)   *P*-value (state) (rest×physical exercise)   *P*-value (interaction) (intensity×state)                      
  ------------------ ------------- ------------------------------------------- -------------------------------------------- ------------------------------------------- ------- ---------- -------
  Epigastric pain    1.54 ± 0.97   1.35 ± 0.74                                 1.55 ± 0.84                                  1.28 ± 0.59                                 0.766   0.018      0.655
  Regurgitation      1.55 ± 0.88   1.39 ± 0.73                                 1.56 ± 1.04                                  1.41 ± 0.92                                 0.895   0.147      1.000
  Nausea             1.38 ± 0.66   1.35 ± 0.70                                 1.45 ± 0.82                                  1.37 ± 0.70                                 0.241   0.429      0.107
  Vomiting           1.06 ± 0.29   1.00 ± 0.00                                 1.14 ± 0.42                                  1.03 ± 0.24                                 0.094   0.012      0.401
  Early satiety      2.11 ± 1.24   1.55 ± 0.97                                 2.23 ± 1.30                                  1.51 ± 0.81                                 0.787   \< 0.001   0.552
  Dysphagia          1.08 ± 0.37   1.06 ± 0.29                                 1.18 ± 0.66                                  1.17 ± 0.61                                 0.080   0.726      0.907
  Bloating           1.93 ± 0.90   1.39 ± 0.69                                 2.04 ± 0.95                                  1.52 ± 0.89                                 0.243   \< 0.001   0.945
  Eructation         2.32 ± 1.18   1.73 ± 0.98                                 2.42 ± 1.30                                  1.96 ± 1.18                                 0.242   \< 0.001   0.647
  Abdominal noise    2.39 ± 1.05   1.65 ± 0.90                                 2.41 ± 1.13                                  1.72 ± 1.02                                 0.729   \< 0.001   0.817
  Abdominal cramps   1.61 ± 0.85   1.28 ± 0.64                                 1.61 ± 0.82                                  1.34 ± 0.65                                 0.751   0.001      0.751
  Flatulence         2.70 ± 1.18   2.10 ± 1.06                                 3.20 ± 1.06                                  2.38 ± 1.15                                 0.004   \< 0.001   0.425
  Blood in stools    1.06 ± 0.29   1.03 ± 0.24                                 1.11 ± 0.52                                  1.08 ± 0.50                                 0.244   0.560      1.000
  Diarrhea           1.45 ± 0.75   1.27 ± 0.53                                 1.56 ± 0.84                                  1.35 ± 0.70                                 0.246   0.021      0.868
  Constipation       1.70 ± 1.07   1.44 ± 0.91                                 1.68 ± 0.94                                  1.38 ± 0.76                                 0.701   0.011      0.898
  Steatorrhea        1.00 ± 0.00   1.00 ± 0.00                                 1.06 ± 0.23                                  1.03 ± 0.17                                 0.013   0.407      0.407
  Mucus in stools    1.14 ± 0.35   1.06 ± 0.29                                 1.15 ± 0.44                                  1.07 ± 0.26                                 0.727   0.037      1.000
  Loss of appetite   1.15 ± 0.36   1.15 ± 0.47                                 1.28 ± 0.72                                  1.18 ± 0.52                                 0.222   0.437      0.437
  Heartburn          1.82 ± 1.06   1.80 ± 1.05                                 1.93 ± 1.10                                  1.65 ± 0.88                                 0.862   0.226      0.273

Values are presented as mean±SD.

###### 

Comparison of Weekly Intensity Index of GI Symptoms during Rest and Physical Exercise

  Symptom            Group         *P*-value (intensity) (moderate×vigorous)   *P*-value (state) (rest×physical exercise)   *P*-value (interaction) (intensity×state)                      
  ------------------ ------------- ------------------------------------------- -------------------------------------------- ------------------------------------------- ------- ---------- -------
  Epigastric pain    1.89 ± 1.40   1.41 ± 0.90                                 1.86 ± 1.30                                  1.59 ± 1.13                                 0.587   0.009      0.459
  Regurgitation      1.63 ± 1.00   1.52 ± 0.86                                 1.87 ± 1.47                                  1.68 ± 1.40                                 0.172   0.283      0.769
  Nausea             1.54 ± 0.95   1.52 ± 0.89                                 1.66 ± 1.01                                  1.39 ± 0.80                                 1.000   0.197      0.246
  Vomiting           1.11 ± 0.65   1.00 ± 0.00                                 1.13 ± 0.51                                  1.04 ± 0.36                                 0.595   0.064      0.791
  Early satiety      2.58 ± 1.65   1.83 ± 1.42                                 1.96 ± 1.21                                  1.59 ± 1.01                                 0.007   0.001      0.234
  Dysphagia          1.06 ± 0.37   1.08 ± 0.41                                 1.31 ± 0.98                                  1.24 ± 0.92                                 0.018   0.806      0.567
  Bloating           2.27 ± 1.32   1.56 ± 0.95                                 2.62 ± 1.39                                  1.66 ± 1.07                                 0.113   \< 0.001   0.372
  Eructation         2.30 ± 1.14   1.69 ± 0.94                                 2.50 ± 1.36                                  2.03 ± 1.16                                 0.050   \< 0.001   0.627
  Abdominal noise    2.70 ± 1.15   1.73 ± 0.99                                 2.82 ± 1.26                                  2.07 ± 1.19                                 0.100   \< 0.001   0.410
  Abdominal cramps   1.82 ± 1.15   1.44 ± 0.98                                 1.96 ± 1.24                                  1.46 ± 0.88                                 0.506   0.001      0.658
  Flatulence         2.93 ± 1.05   2.21 ± 1.11                                 3.06 ± 1.35                                  2.45 ± 1.26                                 0.199   \< 0.001   0.692
  Blood in stools    1.04 ± 0.20   1.01 ± 0.12                                 1.11 ± 0.46                                  1.08 ± 0.44                                 0.082   0.486      1.000
  Diarrhea           1.65 ± 1.14   1.32 ± 0.81                                 1.68 ± 1.05                                  1.48 ± 0.89                                 0.432   0.026      0.586
  Constipation       1.94 ± 1.46   1.58 ± 1.22                                 2.20 ± 1.55                                  1.72 ± 1.27                                 0.229   0.010      0.731
  Steatorrhea        1.07 ± 0.31   1.04 ± 0.20                                 1.04 ± 0.20                                  1.00 ± 0.00                                 0.160   0.160      0.778
  Mucus in stools    1.18 ± 0.46   1.13 ± 0.38                                 1.30 ± 0.78                                  1.13 ± 0.48                                 0.384   0.083      0.384
  Loss of appetite   1.38 ± 0.99   1.41 ± 1.04                                 1.28 ± 0.72                                  1.28 ± 0.70                                 0.279   0.892      0.892
  Heartburn          1.96 ± 1.16   1.82 ± 1.02                                 2.11 ± 1.42                                  1.77 ± 1.12                                 0.690   0.091      0.486

Values are presented as mean±SD.
